<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Frontage Holdings Corp — News on 6ix</title>
<link>https://6ix.com/company/frontage-holdings-corp</link>
<description>Latest news and press releases for Frontage Holdings Corp on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 04 Mar 2026 15:27:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/frontage-holdings-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683685cc78dffbe2df16a368.webp</url>
<title>Frontage Holdings Corp</title>
<link>https://6ix.com/company/frontage-holdings-corp</link>
</image>
<item>
<title>Frontage Laboratories Completes Acquisition of Teddy Lab, Strengthening Global Central Laboratory Capabilities</title>
<link>https://6ix.com/company/frontage-holdings-corp/news/frontage-laboratories-completes-acquisition-of-teddy-lab-strengthening-global-central-laboratory-capabilities-2</link>
<guid isPermaLink="true">https://6ix.com/company/frontage-holdings-corp/news/frontage-laboratories-completes-acquisition-of-teddy-lab-strengthening-global-central-laboratory-capabilities-2</guid>
<pubDate>Wed, 04 Mar 2026 15:27:00 GMT</pubDate>
<description>Frontage Laboratories, Inc. ("Frontage"), a leading global CRO/CDMO, today announced the completion of the acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. ("Teddy Lab"), a leading clinical research laboratory service provider in China. The acquisition aims to enhance Frontage's global laboratory service capabilities and further strengthen its presence in China and the Asia-Pacific region.</description>
</item>
<item>
<title>Frontage Laboratories Expands Early Phase Clinical Capabilities to Support Global Drug Development</title>
<link>https://6ix.com/company/frontage-holdings-corp/news/frontage-laboratories-expands-early-phase-clinical-capabilities-to-support-global-drug-development</link>
<guid isPermaLink="true">https://6ix.com/company/frontage-holdings-corp/news/frontage-laboratories-expands-early-phase-clinical-capabilities-to-support-global-drug-development</guid>
<pubDate>Fri, 30 Jan 2026 17:00:00 GMT</pubDate>
<description>Frontage Laboratories, Inc. ("Frontage"), a global Contract Research, Development and Manufacturing Organization (CRDMO), today announced the expansion of its early phase clinical research capabilities across the United States and China. This strategic growth enhances the company's ability to support pharmaceutical and biotech partners with accelerated, high‑quality clinical development solutions.</description>
</item>
<item>
<title>Frontage Europe Has Relocated Its Bioanalytical Laboratory and Further Expands Its Capabilities</title>
<link>https://6ix.com/company/frontage-holdings-corp/news/frontage-europe-has-relocated-its-bioanalytical-laboratory-and-further-expands-its-capabilities</link>
<guid isPermaLink="true">https://6ix.com/company/frontage-holdings-corp/news/frontage-europe-has-relocated-its-bioanalytical-laboratory-and-further-expands-its-capabilities</guid>
<pubDate>Tue, 27 Jan 2026 17:00:00 GMT</pubDate>
<description>We are pleased to communicate that Frontage Europe, a fully owned subsidiary of Frontage Laboratories Inc., has relocated its bioanalytical laboratory to consolidate all services in a 2,500 square meters facility close to Milan, Italy. This strategic decision represents a step forward to increase efficiency and streamline processes.</description>
</item>
<item>
<title>Frontage CDMO Fully Operational GMP Facility is Ready for Your Needs of Clinical Trials and Commercial Production</title>
<link>https://6ix.com/company/frontage-holdings-corp/news/frontage-cdmo-fully-operational-gmp-facility-is-ready-for-your-needs-of-clinical-trials-and-commercial-production</link>
<guid isPermaLink="true">https://6ix.com/company/frontage-holdings-corp/news/frontage-cdmo-fully-operational-gmp-facility-is-ready-for-your-needs-of-clinical-trials-and-commercial-production</guid>
<pubDate>Thu, 15 Jan 2026 13:00:00 GMT</pubDate>
<description>Frontage Laboratories, Inc., a leading contract development and manufacturing organization (CDMO) announced that its new facility opened in May 2025 had completed GMP facility validation in October 2025, and has been fully operational with on-going Clinical Phase III, PPQ batches and small-scale commercial manufacturing. This new facility is dedicated to drug development and clinical & commercial manufacturing including sterile, oral solid, and liquid dosage forms. This manufacturing facility co</description>
</item>
<item>
<title>Frontage Announces Expansion of Business in Canada with New Leadership</title>
<link>https://6ix.com/company/frontage-holdings-corp/news/frontage-announces-expansion-of-business-in-canada-with-new-leadership</link>
<guid isPermaLink="true">https://6ix.com/company/frontage-holdings-corp/news/frontage-announces-expansion-of-business-in-canada-with-new-leadership</guid>
<pubDate>Tue, 01 Jul 2025 11:00:00 GMT</pubDate>
<description>As part of the strategy in expanding service offerings across the globe, Frontage Holdings Corporation is pleased to announce the appointment of Dr. Abdul Mutlib as the President of Frontage Laboratories, Canada. Dr. Mutlib will spearhead Frontage's growth in the Canadian market as he continues to serve as the Chief Scientific & Strategy Officer for Frontage Laboratories. Dr. Mutlib will have an oversight of the Canadian operations based in Toronto and Vancouver. He will report to Co-Chief Execu</description>
</item>
<item>
<title>Expansion of Frontage Laboratories Continues with Launch of New State-of-the-Art CRDMO Facility in Exton, PA</title>
<link>https://6ix.com/company/frontage-holdings-corp/news/expansion-of-frontage-laboratories-continues-with-launch-of-new-state-of-the-art-crdmo-facility-in-exton-pa</link>
<guid isPermaLink="true">https://6ix.com/company/frontage-holdings-corp/news/expansion-of-frontage-laboratories-continues-with-launch-of-new-state-of-the-art-crdmo-facility-in-exton-pa</guid>
<pubDate>Mon, 02 Jun 2025 17:23:00 GMT</pubDate>
<description>Frontage Laboratories, Inc. officially unveiled its newest Contract Research, Development and Manufacturing Organization (CRDMO) facility during a grand open house event held on May 22, 2025, at its campus in Exton, Pennsylvania.</description>
</item>
</channel>
</rss>